Is There a Medical Procedure to Lift My Spine and Restore My Height?
Can spine compression fractures be fixed and height loss reversed in patients with myeloma? Myeloma expert Dr. Jatin Shah from The University of Texas MD Anderson Cancer Center, responds with a discus...
Author: patientpower
Added: 07/06/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO 2016 highlights for CLL
William Wierda, MD, PhD from the University of Texas MD Anderson Cancer Center, Houston, TX discusses his highlights for chronic lymphocytic leukemia (CLL) from the American Society of Oncology (ASCO)...
Author: VJHemOnc
Added: 06/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 16, 2016 Category: Cancer & Oncology Source Type: podcasts
The risk of infection for CLL patients receiving idelalisib
William Wierda, MD, PhD from the University of Texas MD Anderson Cancer Center, Houston, TX discusses the safety of idelalisib for chronic lymphocytic leukemia (CLL). Dr Wierda outlines the risk of in...
Author: VJHemOnc
Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO 2016: The risk of infection for CLL patients receiving idelalisib
William Wierda, MD, PhD from the University of Texas MD Anderson Cancer Center, Houston, TX discusses the safety of idelalisib for chronic lymphocytic leukemia (CLL). Dr Wierda outlines the risk of in...
Author: VJHemOnc
Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts
INO-VATE trial of inotuzumab ozogamicin: response, efficacy and safety results
Elias Jabbour, MD from the The University of Texas MD Anderson Cancer Center, Houston, TX gives an overview of the results of the INO-VATE trial of inotuzumab ozogamicin (InO) for relapsed/refractory ...
Author: VJHemOnc
Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts
" Oil Magnets " -- The Discovery Files
Microbiologists at The University of Texas at Austin and their colleagues have cracked the genetic code of how bacteria broke down oil to help clean up the Deepwater Horizon oil spill, revealing that some bacteria have far greater potential for consuming oil than was previously known. (Source: The Discovery Files)
Source: The Discovery Files - June 13, 2016 Category: Science Authors: National Science Foundation Source Type: podcasts
Can I As a Myeloma Patient Become Refractory to Certain Monoclonal Antibodies?
Patient Power Community member, Francis, asks “Can refractory, high-risk myeloma patients become refractory to daratumumab?” Myeloma expert Dr. Jatin Shah from the University of Texas MD Anderson Canc...
Author: patientpower
Added: 05/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 19, 2016 Category: Cancer & Oncology Source Type: podcasts
The importance of educating stem cell transplant recipients about tuberculosis and cytomegalovirus
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, discusses the importance about educating stem cell transplant patients about the risk of tuberculosis and cyt...
Author: VJHemOnc
Added: 04/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of a symposium on the role of immunodiagnostics for tuberculosis (TB) and cytomegaloviru...
Author: VJHemOnc
Added: 04/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2016 Category: Cancer & Oncology Source Type: podcasts
ELCC 2016: Phase 1 study of anti-PD-L1 durvalumab plus gefitinib in TKI-naïve patients with EGFR-mutant NSCLC
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Don Gibbons, MD, PhD, from The University of Texas MD Anderson Cancer Center, Houston, TX, discus...
Author: VJOncology
Added: 04/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2016 Category: Cancer & Oncology Source Type: podcasts
T-SPOT assay for tuberculosis and cytomegalovirus - benefits, results and next steps
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, discusses the T-SPOT.TB assay for predicting tuberculosis (TB) and cytomegalovirus (CMV) in stem cell transpl...
Author: VJHemOnc
Added: 04/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 18, 2016 Category: Cancer & Oncology Source Type: podcasts
What Could a New Drug Approval Mean for CLL Patients?
Dr. William Wierda, medical director of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, joins Patient Power to discuss the approval of Venclexta (venetoclax) for use i...
Author: patientpower
Added: 04/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 14, 2016 Category: Cancer & Oncology Source Type: podcasts
Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of an symposium on the role of tuberculosis (TB) and cytomegalovirus (CMV) immunodiagnos...
Author: VJHemOnc
Added: 04/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 13, 2016 Category: Cancer & Oncology Source Type: podcasts
Personalised treatment approach for ALL
Elias Jabbour, MD from University of Texas MD Anderson Cancer Center, Houston, USA explains how patient's individual cirstumstances affect treatment decisions. Age is an important factor for chemother...
Author: PatientPowerEU
Added: 03/04/2016 (Source: Oncology Tube)
Source: Oncology Tube - March 4, 2016 Category: Cancer & Oncology Source Type: podcasts
